Đang chuẩn bị liên kết để tải về tài liệu:
Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant non-small cell lung cancer and brain metastasis: A retrospective study

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The aims of the study were to evaluate potential differences among first-line treatment for EGFR mutant (m+) non-small cell lung cancer (NSCLC) patients with brain metastasis in China and to identify the factors influencing survival outcomes. |

TÀI LIỆU LIÊN QUAN

Evaluating the impact of filming on the number of errors committed by nursing students to determine the efficacy of simulated clinical situations

A review of manufacture, bioavailability, safety and clinical efficacy of milk thistle phytosome

Phytochemical characterization and therapeutic efficacy of Psidium guajava L. in clinical cases of ootitis externa

Phase II, multi-center, open-label, singlearm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): Rationale and design of the ESMMO trial

Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: A non-inferiority randomized clinical trial

Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities

Ebook Anthelmintics clinical pharmacology, uses in veterinary medicine and efficacy: Part 1

The effect of prenatal counseling on breastfeeding self-efficacy and frequency of breastfeeding problems in mothers with previous unsuccessful breastfeeding: A randomized controlled clinical trial

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: A multicenter, randomized, double-blind, comparative, phase 3 clinical trial

ACRNaCT trial protocol: Efficacy of adjuvant chemotherapy in patients with clinical T3b/ T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: A pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial